Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Innotech Precision Medicine Inc. is currently prosecuting applications within the Chemistry & Materials technology area. The portfolio contains 2 pending office actions, which indicates an active level of engagement with the patent office. These 2 pending office actions represent the current workload for the company as it seeks to expand its intellectual property holdings in Chemistry & Materials.
The prosecution is divided between 2 distinct art units and 2 distinct examiners. This structure shows that the company's 2 pending office actions are not concentrated under a single examiner or art unit, providing a variety of perspectives on the patentability of their inventions. For a practitioner, this distribution across 2 distinct examiners means that the prosecution strategy must account for different examination styles.
HANDY, DWAYNE K is the busiest examiner for this company, with a busiest examiner pending count of 1. This means that HANDY, DWAYNE K is responsible for 1 of the 2 pending office actions. The presence of HANDY, DWAYNE K as the busiest examiner, even with a count of 1, reflects the even distribution of the 2 pending office actions across the 2 distinct examiners involved.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HANDY, DWAYNE K | 1 | 62.6% | +25.1% |
| RAMADAN, OMAR | 1 | 25.8% | +56.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17702107 | DEVICE AND METHOD FOR DETECTING INFLAMMATION | RAMADAN, OMAR | 70d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18091902 | SYSTEMS, APPARATUS, AND METHODS FOR DETECTING PATHOGENS | HANDY, DWAYNE K | 146d overdue |
| 17702107 | DEVICE AND METHOD FOR DETECTING INFLAMMATION | RAMADAN, OMAR | 70d overdue |
| Art Unit | Apps |
|---|---|
| 1798 | 1 |
| 1678 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18091902 | SYSTEMS, APPARATUS, AND METHODS FOR DETECTING PATHOGENS | HANDY, DWAYNE K | 1798 | §102 | Final Rejection | 146d overdue | Pending | Dec 30, 2022 |
| 17702107 | DEVICE AND METHOD FOR DETECTING INFLAMMATION | RAMADAN, OMAR | 1678 | §102§103 | Non-Final OA | 70d overdue | Pending | Mar 23, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial